Found: 27
Select item for more details and to access through your institution.
Additional copies of 1q negatively impact the outcome of multiple myeloma patients and induce transcriptomic deregulation in malignant plasma cells.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01075-x
- By:
- Publication type:
- Article
KRD (carfilzomib and lenalidomide plus dexamethasone) for the treatment of relapsed or refractory multiple myeloma in the real-life: a retrospective survey in 123 patients.
- Published in:
- Annals of Hematology, 2020, v. 99, n. 12, p. 2903, doi. 10.1007/s00277-020-04158-4
- By:
- Publication type:
- Article
Adjusted comparison between elotuzumab and carfilzomib in combination with lenalidomide and dexamethasone as salvage therapy for multiple myeloma patients.
- Published in:
- European Journal of Haematology, 2022, v. 108, n. 3, p. 178, doi. 10.1111/ejh.13723
- By:
- Publication type:
- Article
Low-dose rituximab in adult patients with primary immune thrombocytopenia.
- Published in:
- European Journal of Haematology, 2010, v. 85, n. 4, p. 329, doi. 10.1111/j.1600-0609.2010.01486.x
- By:
- Publication type:
- Article
Safety and efficacy of bortezomib-based regimens for multiple myeloma patients with renal impairment: a retrospective study of Italian Myeloma Network GIMEMA.
- Published in:
- European Journal of Haematology, 2010, v. 84, n. 3, p. 223, doi. 10.1111/j.1600-0609.2009.01385.x
- By:
- Publication type:
- Article
An antecedent diagnosis of refractory anemia with excess blasts has no influence on mobilization of peripheral blood stem cells and hematopoietic recovery after autologous stem cell transplantation in acute myeloid leukemia.
- Published in:
- European Journal of Haematology, 2007, v. 78, n. 1, p. 41, doi. 10.1111/j.1600-0609.2006.00777.x
- By:
- Publication type:
- Article
Fludarabine plus cyclophosphamide for the treatment of advanced chronic lymphocytic leukemia.
- Published in:
- European Journal of Haematology, 2003, v. 71, n. 1, p. 23, doi. 10.1034/j.1600-0609.2003.00087.x
- By:
- Publication type:
- Article
Autologous stem-cell transplantation for patients with acute myeloid leukemia aged over 60 yr.
- Published in:
- European Journal of Haematology, 2002, v. 69, n. 4, p. 200, doi. 10.1034/j.1600-0609.2002.02806.x
- By:
- Publication type:
- Article
De novo acute myeloid leukemia with multilineage dysplasia: treatment results and prognostic evaluation from a series of 44 patients treated with fludarabine, cytarabine and G-CSF (FLAG).
- Published in:
- European Journal of Haematology, 2002, v. 68, n. 4, p. 203, doi. 10.1034/j.1600-0609.2002.01651.x
- By:
- Publication type:
- Article
Bendamustine-Bortezomib-Dexamethasone in Heavily Pretreated Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S254, doi. 10.1016/j.clml.2018.07.158
- By:
- Publication type:
- Article
Bendamustine-Bortezomib-Dexametasone (BVD) in the Management of Relapsed and Refractory Multiple Myeloma: A Real-Life Experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S343, doi. 10.1016/j.clml.2017.07.163
- By:
- Publication type:
- Article
Bendamustine-Bortezomib-Dexamethasone (BVD) in the Management of Relapsed and Refractory Multiple Myeloma: A Real-Life Experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e60, doi. 10.1016/j.clml.2017.03.111
- By:
- Publication type:
- Article
Sequential continuous infusion of fludarabine and cytarabine associated with liposomal daunorubicin (DaunoXome®) (FLAD) in primary refractory or relapsed adult acute myeloid leukemia patients.
- Published in:
- Annals of Hematology, 2009, v. 88, n. 2, p. 151, doi. 10.1007/s00277-008-0571-z
- By:
- Publication type:
- Article
Vinorelbine plus intermediate dose cyclophosphamide is an effective and safe regimen for the mobilization of peripheral blood stem cells in patients with multiple myeloma.
- Published in:
- Annals of Hematology, 2006, v. 85, n. 6, p. 394, doi. 10.1007/s00277-005-0058-0
- By:
- Publication type:
- Article
Late relapse of acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy: report of two cases.
- Published in:
- Annals of Hematology, 2004, v. 83, n. 7, p. 484, doi. 10.1007/s00277-003-0842-7
- By:
- Publication type:
- Article
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended follow‐up of a multicenter, retrospective real‐world experience with 321 cases outside of controlled clinical trials.
- Published in:
- Hematological Oncology, 2024, v. 42, n. 4, p. 1, doi. 10.1002/hon.3290
- By:
- Publication type:
- Article
Carfilzomib combined with lenalidomide and dexamethasone (KRd) as salvage therapy for multiple myeloma patients: italian, multicenter, retrospective clinical experience with 600 cases outside of controlled clinical trials.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 5, p. 1009, doi. 10.1002/hon.3035
- By:
- Publication type:
- Article
Continuous sequential infusion of fludarabine and cytarabine for elderly patients with acute myeloid leukaemia secondary to a previously diagnosed myelodysplastic syndrome.
- Published in:
- Hematological Oncology, 2010, v. 28, n. 4, p. 202, doi. 10.1002/hon.943
- By:
- Publication type:
- Article
Continuous infusion idarubicin and intravenous busulphan as conditioning regimen to autologous stem cell transplantation for patients with acute myeloid leukaemia.
- Published in:
- Hematological Oncology, 2009, v. 27, n. 4, p. 198, doi. 10.1002/hon.903
- By:
- Publication type:
- Article
Autologous stem cell transplantation for elderly patients with acute myeloid leukaemia conditioned with continuous infusion idarubicin and busulphan.
- Published in:
- Hematological Oncology, 2009, v. 27, n. 1, p. 40, doi. 10.1002/hon.893
- By:
- Publication type:
- Article
Age has no influence on mobilization of peripheral blood stem cells in acute myeloid leukemia.
- Published in:
- Hematological Oncology, 2007, v. 25, n. 2, p. 84, doi. 10.1002/hon.810
- By:
- Publication type:
- Article
Myeloablative chemotherapy followed by autologous stem cell infusion may overcome the adverse prognostic impact of FLT3 (foetal liver tyrosine kinase 3) mutations in patients with acute myeloid leukaemia and normal karyotype.
- Published in:
- Hematological Oncology, 2007, v. 25, n. 1, p. 1, doi. 10.1002/hon.794
- By:
- Publication type:
- Article
Therapeutic results in patients with relapsed diffuse large B cell Non-Hodgkin's lymphoma achieving complete response only after autologous stem cell transplantation.
- Published in:
- Hematological Oncology, 2006, v. 24, n. 2, p. 73, doi. 10.1002/hon.773
- By:
- Publication type:
- Article
FLT3 mutations have no prognostic impact in elderly patients with acute myeloid leukemia and normal karyotype.
- Published in:
- American Journal of Hematology, 2009, v. 84, n. 8, p. 532, doi. 10.1002/ajh.21458
- By:
- Publication type:
- Article
Safety of Subcutaneous Daratumumab in Anti-CD38 Monoclonal Antibody-Naïve Patients with Plasma Cell Disorders: A Multicenter Real-Life Experience.
- Published in:
- Targeted Oncology, 2023, v. 18, n. 6, p. 885, doi. 10.1007/s11523-023-01001-4
- By:
- Publication type:
- Article
High-dose idarubicin and busulphan as conditioning to autologous stem cell transplantation in adult patients with acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2005, v. 128, n. 2, p. 234, doi. 10.1111/j.1365-2141.2004.05303.x
- By:
- Publication type:
- Article
Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.890376
- By:
- Publication type:
- Article